Entry into the Biomaterials Business and Creation of a Wholly Owned Subsidiary Through the Acquisition of BAB

A theme centered on entering the biomaterials business by acquiring the U.S. biomaterials company BAB through GNI USA. It also involves acquiring the remaining interest in BABL to make it a wholly owned subsidiary and bring the foundation of the business into the group.